These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 12355549

  • 1. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW, Leff MA, Ishibe N, Sinha R, Frazier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE.
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [Abstract] [Full Text] [Related]

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
    Hein DW, Doll MA, Xiao GH, Feng Y.
    Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
    [Abstract] [Full Text] [Related]

  • 5. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA, Xiao GH, Hein DW.
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW.
    Mutat Res; 2002 Sep 30; 506-507():65-77. PubMed ID: 12351146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
    Hou ZD, Xiao ZY, Gong Y, Zhang YP, Zeng QY.
    BMC Pharmacol Toxicol; 2014 Nov 21; 15():64. PubMed ID: 25413361
    [Abstract] [Full Text] [Related]

  • 10. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, Hein DW, Hayes RB.
    Pharmacogenomics; 2006 Sep 21; 7(6):819-29. PubMed ID: 16981843
    [Abstract] [Full Text] [Related]

  • 11. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM, Park SK, Kim SU, Doll MA, Yoo KY, Ahn SH, Noh DY, Hirvonen A, Hein DW, Kang D.
    Cancer Lett; 2003 Jul 10; 196(2):179-86. PubMed ID: 12860276
    [Abstract] [Full Text] [Related]

  • 12. Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.
    Sharma S, Cao X, Wilkens LR, Yamamoto J, Lum-Jones A, Henderson BE, Kolonel LN, Le Marchand L.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul 10; 19(7):1866-70. PubMed ID: 20570911
    [Abstract] [Full Text] [Related]

  • 13. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J, Liang D, Wang Y, Lu C, Wu X.
    Mutat Res; 2005 Mar 07; 581(1-2):97-104. PubMed ID: 15725609
    [Abstract] [Full Text] [Related]

  • 14. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
    Boissy RJ, Watson MA, Umbach DM, Deakin M, Elder J, Strange RC, Bell DA.
    Int J Cancer; 2000 Aug 15; 87(4):507-11. PubMed ID: 10918189
    [Abstract] [Full Text] [Related]

  • 15. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B, Brans R, Coenraads PJ, Dickel H, Bruckner T, Hein DW, Heesen M, Merk HF, Kawakubo Y.
    Br J Dermatol; 2009 Nov 15; 161(5):1130-5. PubMed ID: 19663877
    [Abstract] [Full Text] [Related]

  • 16. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C, Mitrunen K, Wikman H, Husgafvel-Pursiainen K, Dayer P, Benhamou S, Hirvonen A.
    Pharmacogenetics; 1998 Aug 15; 8(4):291-8. PubMed ID: 9731715
    [Abstract] [Full Text] [Related]

  • 17. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 15; 15(1):99-107. PubMed ID: 16434594
    [Abstract] [Full Text] [Related]

  • 18. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
    Matejcic M, Vogelsang M, Wang Y, Iqbal Parker M.
    BMC Cancer; 2015 Mar 18; 15():150. PubMed ID: 25886288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
    Cocco P, Zucca M, Sanna S, Satta G, Nonne T, Angelucci E, Gabbas A, Rais M, Malpeli G, Campagna M, Scarpa A, G Ennas M.
    Hematol Oncol; 2016 Jun 18; 34(2):79-83. PubMed ID: 25689677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.